| Literature DB >> 27230853 |
Mathilde Renaud1,2,3, Claire Guissart4, Martial Mallaret2,3,5, Sacha Ferdinandusse6, David Cheillan7, Nathalie Drouot2, Jean Muller2,3,8,9, Mireille Claustres4, Christine Tranchant1,2,3, Mathieu Anheim1,2,3, Michel Koenig10.
Abstract
Peroxisomal biogenesis disorders (PBDs) consist of a heterogeneous group of autosomal recessive diseases, in which peroxisome assembly and proliferation are impaired leading to severe multisystem disease and early death. PBDs include Zellweger spectrum disorders (ZSDs) with a relatively mild clinical phenotype caused by PEX1, (MIM# 602136), PEX2 (MIM# 170993), PEX6 (MIM# 601498), PEX10 (MIM# 602859), PEX12 (MIM# 601758), and PEX16 (MIM# 603360) mutations. Three adult patients are reported belonging to a non-consanguineous French family affected with slowly progressive cerebellar ataxia, axonal neuropathy, and pyramidal signs. Mental retardation and diabetes mellitus were optional. The age at onset was in childhood or in adolescence (3-15 years). Brain MRI showed marked cerebellar atrophy. Biochemical blood analyses suggested a mild peroxisomal defect. With whole exome sequencing, two mutations in PEX10 were found in the three patients: c.827G>T (novel) causing the missense change p.Cys276Phe and c.932G>A causing the missense change p.Arg311Gln. The phenotypic spectrum related to PEX10 mutations includes slowly progressive, syndromic recessive ataxia.Entities:
Keywords: NGS; PEX10; Peroxisomal biogenesis disorders; Recessive ataxia
Mesh:
Substances:
Year: 2016 PMID: 27230853 DOI: 10.1007/s00415-016-8167-3
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849